Literature DB >> 793403

Macrophage migration inhibition factor activity in the aqueous humor during experimental corneal xenograft and allograft rejection.

N A Sher, D J Doughman, E Mindrup, L A Minaai.   

Abstract

Macrophage migration inhibition factor (MIF), a soluble mediator of delayed hypersensitivity, was assayed for in the aqueous humor of rabbits undergoing corneal graft rejection. Penetrating and interlamellar xenografts and interlamellar allografts were performed in rabbits, and aqueous humor early in the course of xenograft and allograft rejection, and MIF activity was present during the course of the active rejection. This activity returned to near normal after the active rejection resolved. No significant MIF activity could be measured during the nonspecific inflammations produced by alkali burns, multiple paracenteses, intracorneal clove oil, mechanical debriding of the endothelium.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 793403     DOI: 10.1016/0002-9394(76)90061-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Corneal allograft rejection in bilateral penetrating keratoplasty: clinical and laboratory studies.

Authors:  R F Meyer
Journal:  Trans Am Ophthalmol Soc       Date:  1986

2.  Immunological activity to different corneal antigens in patients with corneal diseases.

Authors:  C J Brinkman; W F Treffers; R M Broekhuyse
Journal:  Br J Ophthalmol       Date:  1979-10       Impact factor: 4.638

3.  Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation.

Authors:  S A Rayner; W J King; R M Comer; J D Isaacs; G Hale; A J George; D F Larkin
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

4.  Composition of cellular infiltrates in rejected human corneal allografts.

Authors:  J S Pepose; M S Nestor; K M Gardner; R Y Foos; T H Pettit
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.